Friday, May 24, 2024
Home > Investing > Advisor > GrowLife, Inc. EZ-CLONE Pro Commercial Propagation System on Display at The California State Fair

GrowLife, Inc. EZ-CLONE Pro Commercial Propagation System on Display at The California State Fair

GrowLife, Inc. EZ-CLONE Pro Commercial Propagation System on Display at The California State Fair

KIRKLAND, Wash. – July 23, 2019 — GrowLife, Inc. (OTC: PHOT) (“GrowLife” or the “Company”), one of the nation’s most recognized indoor cultivation product and service providers, today announced that the Company’s leading commercial cloning and propagation system, the EZ-CLONE Pro, is on display at the California State Fair in Sacramento through July 28, 2019.

The 459-site plant cloning system, which was designed to allow plant cultivators to clone industry-leading volumes of consistent and high-quality plants, was developed by GrowLife’s recently majority acquired EZ-CLONE Enterprises, Inc. The system on display at the California State Fair is located in the Agricultural area of the exposition and is currently growing potato clones. This unit offers a direct example of the plant consistency the system offers.

The Company recently announced a patent issuance from the Canadian patent authorities on the system and the Company hopes to receive a similar issuance from the United States Patent and Trademark Office (USPTO) shortly.

“Through this product, GrowLife is poised to distribute the traditional farming methods that many plant growers are using, especially in hemp cultivation,” said GrowLife CEO Marco Hegyi. “Many long-time agriculture industry members are switching their crops to hemp since the passage of the Farm Bill in 2018 which legalized hemp production in the United States. While their experience in growing other plants will be beneficial, growing hemp for biomass or cannabidiol extraction, with less than the legal limit of THC will prove extremely different and more difficult than growing most other plants.”

Hegyi added, “The best way to guarantee the viability, gender and cannabinoid profile of new hemp plants is to grow them from clones. Demand for high-volumes of these raw materials is on the rise and for farmers to produce enough clones, they will need a solution such as our EZ-CLONE Pro unit. By exhibiting our system at the California State Fair, we are offering education on cloning and propagation to some of the largest agricultural farms in the state. This also demonstrates the clone consistency that our system renders through growing various plants and foods. We highly encourage cultivators to visit the system on display to learn more about the benefits of cloning.”

According to Vote Hemp’s U.S. Hemp Crop report, around 78,176 acres of hemp were grown in the U.S in 2018, up from just 23,343 in 2017. This illustrates the massive increase in demand for raw hemp material and the need for healthier and more viable plants. With rough estimates of around 2,000 plants per acre when growing hemp for cannabidiol (CBD) extraction, and most hemp producers planting and harvesting between 3-4 times per year, the demand for seeds or clones could surpass 500 million annually this year.

All stock recommendations and comments are the opinion of writer.

Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion.

All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.

You should be aware of the risks involved in stock investing, and you use the material contained herein at your own risk. Neither nor any of its suppliers guarantee its accuracy or validity, nor are they responsible for any errors or omissions which may have occurred. The analysis, ratings, and/or recommendations made by, and/or any of its suppliers do not provide, imply, or otherwise constitute a guarantee of performance. is comprised of reports, if any, embodying a unique system of stock analysis. Accuracy and completeness cannot be guaranteed. Users should be aware of the risks involved in stock investments. It should not be assumed that future results will be profitable or will equal past performance, real, indicated or implied.

The material on this website are provided for information purpose only. does not accept liability for your use of the website. The website is provided on an “as is” and “as available” basis, without any representations, warranties or conditions of any kind.